Palavra-chave: LYMPHOMA

TCELL BRAZIL PROJECT NON-HODGKIN LYMPHOMA PRE RITUXIMAB ERA METHOTREXATE KINASE CRANIAL NERVES NON-HODGKIN CUTIS LAXA CHILDREN MALIGNANCY T/NK-CELL KILLER CELLS INTRATHECAL DIFFUSE B-CELL T-CELL/EPIDEMIOLOGY PROGNOSTIC FACTOR IMMUNOPHENOTYPE NCCN-IPI ANAPLASTIC NON-HODGKIN´S ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS UNILATERAL TONSILAR ENLARGMENT PALATINE TONSILS ADOLESCENT PROGNOSIS HLA RECEPTOR T-CELL/PATHOLOGY PHENOTYPING TRANSPLANTATION, AUTOLOGOUS HODGKIN DISEASE/DRUG THERAPY IMMUNOHISTOCHEMISTRY ADMINISTRATION & DOSAGE THERAPEUTIC TRANSPLANTATION NATURAL-KILLER MAGNETIC RESSONANCE HEMATOPOIETIC STEM CELL TRANSPLANTATION DNA AGGRESSIVE NON-HODGKIN MORPHOLOGY RITUXIMAB LYMPH NODE DIFUSE LARGE B-CELL LYMPHOMA TONSILLAR NEOPLASM GENE THETA 1 (GSTT1) T-CELL PROJECT CENTRAL NERVOUS SYSTEM DNA-ANEUPLOIDY TONSILLAR ASYMMETRY LYMPHOMA NON-HODGKIN GLUTATHIONE S-TRANSFERASE MU1 HEMATOLOGIC NEOPLASM TONSIL BRAZILIANS CELL PROLIFERATION AUTOLOGOUS LATIN-AMERICAN GROUO OF LYMPHOMAS (GELL) IMMUNOPHENOTYPING POLYMORPHISMS AGNORS LYMPHADENOPHATY